Complementary and Alternative Medicine in Major Depressive Disorder: The American Psychiatric Association Task Force Report

Center for Women's Mental Health, Massachusetts General Hospital, Boston, MA 02114, USA.
The Journal of Clinical Psychiatry (Impact Factor: 5.5). 06/2010; 71(6):669-81. DOI: 10.4088/JCP.10cs05959blu
Source: PubMed


To review selected complementary and alternative medicine (CAM) treatments for major depressive disorder (MDD).
Authors of this report were invited participants in the American Psychiatric Association's Task Force on Complementary and Alternative Medicine.
The group reviewed the literature on individual CAM treatments for MDD, methodological considerations, and future directions for CAM in psychiatry. Individual CAM treatments were reviewed with regard to efficacy in MDD, as well as risks and benefits. Literature searches included MEDLINE and PsycINFO reviews and manual reference searches; electronic searches were limited to English-language publications from 1965 to January 2010 (but manual searches were not restricted by language). Treatments were selected for this review on the basis of (1) published randomized controlled trials in MDD and (2) widespread use with important clinical safety or public health significance relevant to psychiatric practice. An action plan is presented based on needs pertaining to CAM and psychiatry.
Consensus was reached by group conferences. Written iterations were drafted and sent out among group members prior to discussion, resolution of any differences of interpretation of evidence, and final approval.
A review of randomized controlled trials for commonly used CAM treatments such as omega-3 fatty acids, St John's wort (Hypericum), folate, S-adenosyl-L-methionine (SAMe), acupuncture, light therapy, exercise, and mindfulness psychotherapies revealed promising results. More rigorous and larger studies are recommended. Each CAM treatment must be evaluated separately in adequately powered controlled trials. At this time, several CAM treatments appear promising and deserve further study. The greatest risk of pursuing a CAM therapy is the possible delay of other well-established treatments. Clinical, research, and educational initiatives designed to focus on CAM in psychiatry are clearly warranted due to the widespread use of CAM therapies.

Download full-text


Available from: David Mischoulon, Mar 30, 2014
  • Source
    • "The most recent meta-analysis showed a moderate effect of omega-3 supplementation in individuals with a diagnosis of depression (Appleton et al., 2010). n-3 PUFAs may be most efficacious when given as an adjunct to antidepressant medication (Freeman et al., 2010). While most studies have investigated the association of n-3 PUFAs with mood states or symptoms, a few studies have focused on cognition. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Beneficial effects of omega-3 fatty acids have been reported for several psychiatric disorders, particularly for depression. Association studies show a relationship between omega-3 intake and depression risk. Meta-analyses of clinical trials have shown a moderate effect of supplementation on depressive symptoms, but not on normal mood states. Few studies have investigated effects on cognition. The purpose of this study was to examine effects of omega-3 supplements on cognition and mood of recovered depressed individuals. Seventy-one participants were randomized to receive either omega-3 or placebo for four weeks in a randomized double-blind design. Results showed small effects of omega-3 supplementation on aspects of emotional decision-making and on self-reported states of depression and tension. Some of the effects were confounded by learning effects. No significant effects were observed on memory, attention, cognitive reactivity and depressive symptoms. While inconclusive, the present findings may indicate that omega-3 supplementation has selective effects on emotional cognition and mood in recovered depressed participants.
    Journal of Psychopharmacology 10/2011; 26(5):738-43. DOI:10.1177/0269881111424928 · 3.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Persons using one group of complementary and alternative medicine (CAM) may differ in important ways from users of other CAM therapies. The aim of this study was to characterize the United States (US) adult population using exclusively mind-body medicine (MBM) and to determine if their characteristics differed from those using exclusively non-vitamin natural products. Using the 2007 National Health Interview Survey (NHIS) and its periodic supplement on CAM use, descriptive characteristics of exclusive MBM users, as well as those using exclusively non-vitamin natural products were identified. A total of 75,764 persons completing the 2007 NHIS with adults aged 18 years and older. Characteristics of MBM users, prevalence of MBM use, and characteristics of exclusive MBM users compared to exclusive non-vitamin natural product users. Among CAM users (N = 83,013,655), 21.8% of the adult population (age 18 or older) reported using exclusive MBM therapy. In multivariate models, exclusive MBM use was associated with female gender, higher educational attainment, younger age, residing in Northeast US, being Asian or black race, and a current smoker compared to those using exclusive non-vitamin natural products. Using bivariate comparisons, individuals that exclusively used MBM were more likely to be white females (60.5%), in a younger age category (18-39 years), educated beyond high school (68.3%), and more likely from the Southern US (32.4%). A greater level of depression in MBM users was noted compared to non-vitamin natural product users (6.6%).
    EXPLORE The Journal of Science and Healing 07/2013; 9(4):219-225. DOI:10.1016/j.explore.2013.04.001 · 1.00 Impact Factor
  • Source

    The Journal of Clinical Psychiatry 06/2010; 71(6):667-8. DOI:10.4088/JCP.10f06161blu · 5.50 Impact Factor
Show more